Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

USFDA grants FTD to efanesoctocog alfa for hemophilia A treatment

pharmaceutical-business-reviewFebruary 25, 2021

Tag: FDA , Sanofi , Hemophilia A , Efanesoctocog alfa , Sobi

PharmaSources Customer Service